Article
Interleukin-6 -634G>C genetic polymorphism is associated with prognosis following surgery for advanced thoracic esophageal squamous cell carcinoma.
Digestive surgery - 1 Jan 2012
Motoyama Satoru, Nakatsu Toshinobu, Miura Masatomo, Hinai Yudai, Minamiya Yoshihiro, Ogawa Jun-ichi
Abstract excerpt
OBJECTIVE: Systemic and/or local interleukin-6 (IL-6) reportedly plays an active role in the progression and prognosis of thoracic esophageal squamous cell carcinoma (TESCC). We assessed the associations between IL-6 and IL-6 receptor (IL-6R) genetic polymorphisms, tumoral IL-6 expression and survival rates following surgery. METHODS: The study participants were 63 Japanese patients treated between 2003 and 2008...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
